US FDA approves label update for Kite's (GILD) Yescarta for relapsed or refractory PCNSL
The FDA's approval for Kite's Yescarta label update reflects a significant advancement in the treatment options for patients with relapsed or refractory PCNSL, potentially enhancing Gilead Sciences' market position in the oncology space.
Iran's Foreign Ministry spokesperson says US-Iran talks for Friday are over for now, unsure when negotiations might restart
Stellantis (STLAM IM) CFO says co. is still in negotiations with suppliers over payments related to suspended EV models
US FDA approves label update for Kite's (GILD) Yescarta for relapsed or refractory PCNSL
Canadian Unemployment Rate (Jan) 6.5% vs. Exp. 6.8% (Prev. 6.8%)
Canadian Participation Rate (Jan) 65% (Prev. 65.4%)
Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.
This regulatory approval could lead to increased sales and investor interest, particularly as the biotech sector looks for growth catalysts. Watch for potential movement in GILD's stock price as this could drive sentiment and influence healthcare valuations more broadly.
Related headlines
- Meta (META) has launched WhatsApp bill payments in India, which will integrate 22,722 billers27 min ago
- Nvidia (NVDA) confirms it is to acquire Hugging Face for USD 12.93bln; Hugging Face will remain an open platform38 min ago
- France reportedly begins tests on Tesla's (TSLA) self-driving technology, sources suggest; results are expected for FSD advanced driver-assistance systems are expected in mid-to-late September2 hours ago
- US Daily Equity Opening News - MSFT to report quarterly Azure sales; AVGO slips on outlook; HPE falls amid supply constraints; VRNS in take-private talks; Elliott urges DTEGY to reconsider TMUS merger; DEC to acquire Birch Resources for USD 1.8bln4 hours ago
- Micron (MU) plans to roughly double its HBM production capacity to about 100,000 wafers per month by year-end, ET reports5 hours ago
- Microsoft (MSFT) will report two segments in FY27: Agents and Infra, and Devices and Consumer; Restated Q4 Azure revenue of USD 29.42bln.16 hours ago
- Broadcom Inc. (AVGO) Q3 2026 (USD): Adj. EPS 3.32 (exp. 3.22), Revenue 29.59bln (exp. 29.24bln); Q4 revenue view 34.8bln (exp. 35.05bln)16 hours ago
- Newsquawk Daily US Earnings Estimates - 3rd September: CIEN19 hours ago
- GE Vernova (GEV) supplies 16 turbines for ESB's 96 MW Chleansaid wind farm in Scottish highlands1 hour ago
- Campbell's (CPB) Q4 2026 (USD): Adj. EPS 0.39 (exp. 0.40), revenue 2.14bln (exp. 2.15bln). Cuts quarterly dividend to accelerate debt reduction 1 hour ago
- JPMorgan (JPM) reduced lending to Jane Street for bond trading in 2025 as the US bank pushed into bond trading, according to FT15 hours ago
- Hewlett Packard Enterprise Co. (HPE) Q3 (USD) Adj. EPS 1.11 (exp. 0.93), Revenue 12.20bln (exp. 11.95bln)16 hours ago
- US President Trump clarifies that Commerce Secretary Lutnick had Venezuela on his mind when he said nobody was killed, adds that 18 people were killed in Iran1 hour ago
- US President Trump posts image of 20mln BPD through the Hormuz vs. 18mln BPD before1 hour ago
- [MARKET ANALYSIS] European bourses tilt higher, Elliott reportedly pushes DTE GY to scrap TMUS merger; AVGO misses Q4 guidance estimates4 hours ago
- [MARKET ANALYSIS] Crude takes a breather after a choppy mid-week; metals mixed4 hours ago
- [MARKET ANALYSIS] Yields slip off best levels as energy benchmarks edge lower; JGBs in focus following a GPIF meeting and BoJ sources4 hours ago
- EUROPEAN OPEN: EZJ LN & ITH LN join FTSE 100, ENT LN & PSN LN to leave; DTE GY faces Elliott push against TMUS merger; VOD LN to launch first UK TV service; SHEL LN acquires BP/ LN stakes in offshore blocks5 hours ago
- European Equity pre-Market Summary - 3rd September 2026: Choppy Asia-Pac trade as South Korean chip names fall in late trade6 hours ago
- [MARKET ANALYSIS] Asia-Pac stocks took impetus from the rebound on Wall St as yields eased9 hours ago
The whole workspace, free to try.
Try it free